GSK and Pfizer Form Consumer Healthcare Joint Venture

By Michelle Liu

Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)

Published: 22 Dec-2018

DOI: 10.3833/pdr.v2018.i12.2387     ISSN: 1756-7874

Section: Joint Venture

Fulltext:

Abstract

In a bid to free up capital for R&D investment, GlaxoSmithKline (GSK) has entered into an agreement with Pfizer to combine their respective consumer health businesses and form a joint venture with combined 2017 sales of approximately £9...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details